CNFA — Canafarma Hemp Products Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -322.59% | ||
| Operating Margin | 2792.87% | ||
Financial Summary
| Year End 30th Jun | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | 1.8 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CanaFarma Hemp Products Corp. is a Canada-based fully integrated hemp products brand company. The Company is engaged in the business of growing, manufacturing, processing and selling hemp oil via an online distribution platform. The Company has three hemp-based products, such as chewing gum, tincture and creams, all of which are distributed and sold under its YOOFORIC brand. Its YOOFORIC tincture is a concentrated liquid herbal extract that is made by soaking herbs and other plant parts in alcohol for weeks to extract the active constituents. It has a YOOFORIC hemp oil-infused cream for joint and muscle support, and hemp oil-infused acne cream to combat skin conditions related specifically to acne. The Company’s YOOFORIC chewing gum is produced in Europe and imported into the United States.
Directors
- Last Annual
- June 30th, 2020
- Last Interim
- March 31st, 2021
- Incorporated
- June 6th, 2017
- Public Since
- March 19th, 2020
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 195,606,145
- Address
- 2080 - 777 Hornby Street, VANCOUVER, V6Z1S4
- Web
- https://www.canafarmacorp.com/News#contacts
- Phone
- Auditors
- Urish (Popeck) & Company
Similar to CNFA
1933 Industries
Canadian Securities Exchange
1CM
Canadian Securities Exchange
Acreage Holdings
Canadian Securities Exchange
Adastra Holdings
Canadian Securities Exchange
Aion Therapeutic
Canadian Securities Exchange
FAQ
As of Today at 18:04 UTC, shares in Canafarma Hemp Products are trading at CA$0.05. This share price information is delayed by 15 minutes.
Shares in Canafarma Hemp Products last closed at CA$0.05 and the price had moved by -82.14% over the past 365 days. In terms of relative price strength the Canafarma Hemp Products share price has underperformed the Toronto Stock Exchange 300 Composite Index by -84.15% over the past year.
There is no consensus recommendation for this security.
Canafarma Hemp Products does not currently pay a dividend.
Canafarma Hemp Products does not currently pay a dividend.
Canafarma Hemp Products does not currently pay a dividend.
To buy shares in Canafarma Hemp Products you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.05, shares in Canafarma Hemp Products had a market capitalisation of .
Here are the trading details for Canafarma Hemp Products:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: CNFA
Based on an overall assessment of its quality, value and momentum Canafarma Hemp Products is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Canafarma Hemp Products. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -47.89%.
As of the last closing price of CA$0.05, shares in Canafarma Hemp Products were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Canafarma Hemp Products PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Canafarma Hemp Products' directors